Inovio Pharmaceuticals Inc
INO2.300USD
-0.010-0.43%
종가 09/19, 16:00（ET）시세는 15분 지연됩니다
84.45M시가총액
손실P/E TTM
자세한 내용은 Inovio Pharmaceuticals Inc 회사
Inovio Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines pipeline include INO-3107 for HPV-related recurrent respiratory papillomatosis (RRP); INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, or OPSCC; VGX-3100 for the treatment of Anal or Perianal HSIL; INO-5401 for the treatment of Glioblastoma Multiforme (GBM), and INO-5401 for the Treatment of Glioblastoma Multiforme (GBM). Its lead candidate is INO-3107 for the treatment of RRP, a rare and debilitating disease of the respiratory tract caused by HPV infection. Its DNA medicines platform consists of DNA plasmids and its CELLECTRA devices, which are used to deliver the DNA plasmids into the cell. Its CELLECTRA device portfolio consists of two models.
회사 정보
종목 코드 INO
회사 이름Inovio Pharmaceuticals Inc
상장일Dec 08, 1998
CEODr. Jacqueline Elizabeth Shea, Ph.D.
직원 수134
유형Ordinary Share
회계 연도 종료Dec 08
주소660 W. Germantown Pike
도시PLYMOUTH MEETING
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호19462
전화18584103134
웹사이트https://www.inovio.com/
종목 코드 INO
상장일Dec 08, 1998
CEODr. Jacqueline Elizabeth Shea, Ph.D.
회사 임원
이름
이름/직위
직위
주식 보유
변동
Dr. David B. Weiner, Ph.D.
Dr. David B. Weiner, Ph.D.
Director
Director
86.62K
+2.57%
Dr. Jacqueline Elizabeth Shea, Ph.D.
Dr. Jacqueline Elizabeth Shea, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
59.69K
+28.22%
Dr. Laurent M. Humeau, Ph.D.
Dr. Laurent M. Humeau, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
32.62K
+10.36%
Mr. Peter D. Kies
Mr. Peter D. Kies
Chief Financial Officer
Chief Financial Officer
30.63K
+7.76%
Mr. Simon X. Benito
Mr. Simon X. Benito
Independent Chairman of the Board
Independent Chairman of the Board
12.19K
+21.62%
Ms. Wendy L. Yarno
Ms. Wendy L. Yarno
Independent Director
Independent Director
10.51K
+25.97%
Dr. Roger D. Dansey, M.D.
Dr. Roger D. Dansey, M.D.
Independent Director
Independent Director
8.92K
+32.11%
Ms. Lota S. Zoth, CPA
Ms. Lota S. Zoth, CPA
Independent Director
Independent Director
8.73K
+33.04%
Mr. Jay P. Shepard
Mr. Jay P. Shepard
Non-Executive Independent Vice Chairman of the Board
Non-Executive Independent Vice Chairman of the Board
--
--
Dr. Ann Calby Miller, M.D.
Dr. Ann Calby Miller, M.D.
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. David B. Weiner, Ph.D.
Dr. David B. Weiner, Ph.D.
Director
Director
86.62K
+2.57%
Dr. Jacqueline Elizabeth Shea, Ph.D.
Dr. Jacqueline Elizabeth Shea, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
59.69K
+28.22%
Dr. Laurent M. Humeau, Ph.D.
Dr. Laurent M. Humeau, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
32.62K
+10.36%
Mr. Peter D. Kies
Mr. Peter D. Kies
Chief Financial Officer
Chief Financial Officer
30.63K
+7.76%
Mr. Simon X. Benito
Mr. Simon X. Benito
Independent Chairman of the Board
Independent Chairman of the Board
12.19K
+21.62%
Ms. Wendy L. Yarno
Ms. Wendy L. Yarno
Independent Director
Independent Director
10.51K
+25.97%
수익 분석
FY2025Q1
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
데이터 없음
지역별USD
이름
수익
비율
United States
65.34K
0.00%
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Sat, Aug 23
마지막 업데이트: Sat, Aug 23
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
3.78%
Deep Track Capital LP
3.73%
BofA Global Research (US)
2.39%
BlackRock Institutional Trust Company, N.A.
0.98%
Geode Capital Management, L.L.C.
0.82%
기타
88.30%
주주
주주
비율
The Vanguard Group, Inc.
3.78%
Deep Track Capital LP
3.73%
BofA Global Research (US)
2.39%
BlackRock Institutional Trust Company, N.A.
0.98%
Geode Capital Management, L.L.C.
0.82%
기타
88.30%
주주 유형
주주
비율
Hedge Fund
6.74%
Investment Advisor
6.52%
Research Firm
3.29%
Investment Advisor/Hedge Fund
2.18%
Individual Investor
0.54%
Bank and Trust
0.26%
Venture Capital
0.04%
기타
80.43%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
303
13.60M
26.69%
-1.85M
2025Q1
358
13.94M
38.02%
-1.87M
2024Q4
376
13.66M
38.08%
+2.74M
2024Q3
379
8.99M
34.33%
-1.39M
2024Q2
391
8.36M
32.11%
+1.80M
2024Q1
412
4.61M
19.75%
-2.01M
2023Q4
431
4.68M
20.64%
-2.86M
2023Q3
449
5.16M
23.15%
-3.37M
2023Q2
462
6.56M
29.43%
-5.01M
2023Q1
491
10.80M
49.36%
-1.98M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
2.03M
3.98%
+355.37K
+21.23%
Mar 31, 2025
Deep Track Capital LP
3.12M
6.12%
--
--
Mar 31, 2025
BofA Global Research (US)
1.30M
2.56%
+664.00K
+103.59%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.15M
4.22%
+393.45K
+22.37%
Mar 31, 2025
Geode Capital Management, L.L.C.
846.80K
1.66%
+218.30K
+34.73%
Mar 31, 2025
Northern Trust Investments, Inc.
461.70K
0.91%
+242.90K
+111.02%
Mar 31, 2025
Morgan Stanley & Co. LLC
108.29K
0.21%
+36.23K
+50.28%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Sep 6
마지막 업데이트: Sat, Sep 6
이름
비율
Invesco RAFI US 1500 Small-Mid ETF
0%
ProShares Hedge Replication ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
Fidelity Enhanced Small Cap ETF
0%
iShares Micro-Cap ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Vanguard US Momentum Factor ETF
0%
ProShares Ultra Nasdaq Biotechnology
0%
Invesco RAFI US 1500 Small-Mid ETF
비율0%
ProShares Hedge Replication ETF
비율0%
Proshares Ultra Russell 2000
비율0%
ProShares UltraPro Russell2000
비율0%
Fidelity Enhanced Small Cap ETF
비율0%
iShares Micro-Cap ETF
비율0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
비율0%
Vanguard US Momentum Factor ETF
비율0%
ProShares Ultra Nasdaq Biotechnology
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Jan 23, 2024
Merger
12→1
Jan 23, 2024
Merger
12→1
Jan 23, 2024
Merger
12→1
Jan 23, 2024
Merger
12→1
날짜
유형
비율
Jan 23, 2024
Merger
12→1
Jan 23, 2024
Merger
12→1
Jan 23, 2024
Merger
12→1
Jan 23, 2024
Merger
12→1
